OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MicroRNAs and the DNA damage response: How is cell fate determined?
Hartwig Visser, Adam D. Thomas
DNA repair (2021) Vol. 108, pp. 103245-103245
Closed Access | Times Cited: 16
Hartwig Visser, Adam D. Thomas
DNA repair (2021) Vol. 108, pp. 103245-103245
Closed Access | Times Cited: 16
Showing 16 citing articles:
MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review
Hafiz Muhammad Husnain Azam, Rosa Rößling, Christiane Geithe, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 5
Hafiz Muhammad Husnain Azam, Rosa Rößling, Christiane Geithe, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 5
Olaparib increases chemosensitivity by upregulating miR-125a-3p in ovarian cancer cells
Zehua Wang, Tao Pu, Weimin Miao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Zehua Wang, Tao Pu, Weimin Miao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Dynamical Analysis of a Boolean Network Model of the Oncogene Role of lncRNA ANRIL and lncRNA UFC1 in Non-Small Cell Lung Cancer
Shantanu Gupta, Ronaldo F. Hashimoto
Biomolecules (2022) Vol. 12, Iss. 3, pp. 420-420
Open Access | Times Cited: 23
Shantanu Gupta, Ronaldo F. Hashimoto
Biomolecules (2022) Vol. 12, Iss. 3, pp. 420-420
Open Access | Times Cited: 23
Modulation of AKT Pathway-Targeting miRNAs for Cancer Cell Treatment with Natural Products
Jun‐Ping Shiau, Ya-Ting Chuang, Ching‐Yu Yen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3688-3688
Open Access | Times Cited: 12
Jun‐Ping Shiau, Ya-Ting Chuang, Ching‐Yu Yen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3688-3688
Open Access | Times Cited: 12
A Brief Review on Chemoresistance; Targeting Cancer Stem Cells as an Alternative Approach
Belén Toledo, Aitor González-Titos, Pablo Hernández-Camarero, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4487-4487
Open Access | Times Cited: 11
Belén Toledo, Aitor González-Titos, Pablo Hernández-Camarero, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4487-4487
Open Access | Times Cited: 11
The regulatory roles of the E3 ubiquitin ligase NEDD4 family in DNA damage response
Xinxin Lu, Haiqi Xu, Jiaqi Xu, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 12
Xinxin Lu, Haiqi Xu, Jiaqi Xu, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 12
MicroRNA-145 Impairs Classical Non-Homologous End-Joining in Response to Ionizing Radiation-Induced DNA Double-Strand Breaks via Targeting DNA-PKcs
Sudhanva M. Srinivasa, Gurusamy Hariharasudhan, Semo Jun, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1509-1509
Open Access | Times Cited: 9
Sudhanva M. Srinivasa, Gurusamy Hariharasudhan, Semo Jun, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1509-1509
Open Access | Times Cited: 9
New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs
Bianca O. Pîrlog, Silvina Iluț, Radu Pîrlog, et al.
Expert Reviews in Molecular Medicine (2023) Vol. 25
Closed Access | Times Cited: 4
Bianca O. Pîrlog, Silvina Iluț, Radu Pîrlog, et al.
Expert Reviews in Molecular Medicine (2023) Vol. 25
Closed Access | Times Cited: 4
Exosomal miRNAs as Participators of Hexavalent Chromium-Induced Genotoxicity and Immunotoxicity: A Two-Stage Population Study
Shiyi Hong, Zekang Su, Yali Zhang, et al.
Environmental Science & Technology (2024)
Closed Access | Times Cited: 1
Shiyi Hong, Zekang Su, Yali Zhang, et al.
Environmental Science & Technology (2024)
Closed Access | Times Cited: 1
Qin Guo, Yujia Li, Yuan Chen, et al.
IUBMB Life (2022) Vol. 74, Iss. 6, pp. 508-518
Closed Access | Times Cited: 6
Multiple Genetic Polymorphisms within microRNA Targets and Homologous microRNA-Binding Sites: Two More Factors Influencing microRNA-Mediated Regulation of Gene Expression
Miruna Giurgiu, Robert F. Kaltenbach, Franziska Ahrend, et al.
IntechOpen eBooks (2023)
Open Access | Times Cited: 3
Miruna Giurgiu, Robert F. Kaltenbach, Franziska Ahrend, et al.
IntechOpen eBooks (2023)
Open Access | Times Cited: 3
Cellular senescence in acute kidney injury: Target and opportunity
Ting Li, Kexin Yang, Wei Gao, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 706, pp. 149744-149744
Closed Access
Ting Li, Kexin Yang, Wei Gao, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 706, pp. 149744-149744
Closed Access
Olaparib increases chemosensitivity by upregulating miR-125a-3p in ovarian cancer cells
Zehua Wang, Tao Pu, Yi Gao, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Zehua Wang, Tao Pu, Yi Gao, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Prognostic Significance of MicroRNAs in Medulloblastoma: A Systematic Review and Meta-Analysis
Haima Li, Jian Wen, Dongdong Li, et al.
International Journal of Nursing and Health Care Research (2023) Vol. 6, Iss. 3
Open Access
Haima Li, Jian Wen, Dongdong Li, et al.
International Journal of Nursing and Health Care Research (2023) Vol. 6, Iss. 3
Open Access
Precision Targeting of Non-Small Cell Lung Cancer: Identifying Optimal Drug Targets and FDA-Approved Combinations for Enhanced Therapeutic Efficacy
Pranabesh Bhattacharjee, Aditya Lahiri, N. Peter Reeves, et al.
(2023), pp. 230-237
Closed Access
Pranabesh Bhattacharjee, Aditya Lahiri, N. Peter Reeves, et al.
(2023), pp. 230-237
Closed Access
